FAS LIGAND-EXPRESSING HEMA- TOPOIETIC CELLS FOR TRANSPLANTATION

Details for Australian Patent Application No. 2002250333 (hide)

Owner JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE

Inventors WHARTENBY, Katherine; PARDOLL, Drew, M.; CIVIN, Curt, I.; DRACHMAN, Daniel

Pub. Number AU-A-2002250333

PCT Pub. Number WO2002/072798

Priority 60/275,615 13.03.01 US

Filing date 13 March 2002

Wipo publication date 24 September 2002

International Classifications

C12N 005/02 Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 031/70 - Carbohydrates

C12N 005/06 Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 015/00 Mutation or genetic engineering

C12N 015/74 Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002250333

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002250334-SHIELDING COVER FOR FIBER OPTIC TRANSCEIVER

2002250332-Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes